Atlas of Psoriatic Arthritis

This comprehensive visual reference contains over 150 images from a wide gamut of variations of the disease, as well as charts and tables detailing the most up-to-date information on patient susceptibility, incidence, and symptoms, providing the clinical presentation of the disease, as well as radiographic, ultrasound, and MRI images to highlight the role of imaging in psoriatic arthritis. Although several proposed methods for classifying PsA have been published, none has been widely accepted or validated. This book proposes the use of an amended version of the Moll and Wright method, and functions mostly as a visual reference and data source of the most up-to-date findings and comprehensive images of PsA. The book includes sections on juvenile psoriatic arthritis which aid practitioners in distinguishing the characteristics and features of the disease in children, as well as discussions of clinical drug trials.The book will be of particular interest to rheumatologists, dermatologists, and family practitioners.

Philip J. Mease, MD, is a clinical professor at the University of Washington School of Medicine in Seattle, where he has also been chief resident and fellow in rheumatology, and is chief of rheumatology clinical research at the Swedish Hospital Medical Center. He is highly involved in clinical trials of new therapies for a number of rheumatic disease conditions, (including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, osteoarthritis, lupus, fibromyalgia and osteoporosis,) and is a founding organizer of GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis.) Publications include numerous articles and book contributions. Philip Mease also sits on review boards for The Journal of Rheumatology, Arthritis & Rheumatism, and The Annals of the Rheumatic Diseases and has received the Medical Communicator Award of the American College of Rheumatology. Dr Mease chairs / co-chairs three working groups of OMERACT (Outcome Measures in Rheumatology): psoriatic arthritis, fibromyalgia and single joint assessment. He is also on the medical advisory boards of pharmaceutical and biotechnology companies, the Lupus Foundation, the Psoriasis Foundation, and the Northwest Arthritis & Osteoporosis Institute. With a strong interest in education, he is also a part of the speakers’ bureaus of the Arthritis Foundation, Lupus Foundation, National Psoriasis Foundation, Wyeth Ayerst, SmithKline Beecham, Genelab Technologies, Proctor & Gamble – to name but a few. Philip S. Helliwell, BM, BCh, is currently senior lecturer in rheumatology at the University of Leeds, Academic Unit of Musculoskeletal & Rehabilitation Medicine. His interests include chronic pain, disability, and communication. He has written about the Moll and Wright classification criteria for diagnosing PsA, making the case for retaining at least the two subgroups of peripheral and axial disease and splitting the peripheral disease into oligo- and polyarthritis.